WHO ICTRP trial
High blood pressure
CTRI/2018/03/012871 · Clinical Trials Registry India (CTRI) · Recruiting
Key facts
| Trial ID | CTRI/2018/03/012871 |
|---|---|
| Public title | High blood pressure |
| Scientific title | Evaluation of the Efficacy of Sharbat-e-Unnab in Primary Hypertension.-An open labeled randomized standard controlled study. |
| Primary sponsor | National Institute of Unani Medicine |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Countries | India |
| Conditions | Health Condition 1: null- Primary Hypertension |
| Interventions | Intervention1: Sharbat-e-Unnab: 25ml BD, oral Route, for the duration of 42 days Control Intervention1: Atenolol 25mg: Oral route, 1 OD, for the duration of 42 days. |
| Registration date | Mar 26, 2018 |
| Target size | 40 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: